NineSigma, representing a global food manufacturer with sales of multi-billion dollars, seeks technologies to measure or estimate blood glucose levels in a non-invasive manner. In this RFP, proposals for technology that is intended for human use and is at least in the prototype stage.
The average life expectancy grows longer globally. The significance of technologies that offer simple ways to monitor the human body conditions is becoming greater. The Client has worked on the development of non-invasive blood glucose monitoring technology with great usability. They have faced challenges in terms of accuracy and other